In a preliminary ruling and strategic options case for endocrine disruptors on Tuesday 20 September, the European General Court ruled that the European Commission does not have the right to refuse public access to its internal documents simply on the grounds that this would compromise its decision-making process if it does not provide tangible evidence to demonstrate this.
The case in question (T-51/15) arose from the European Commission’s refusal in 2014 to allow access to 17 documents...